Solarea Bio, Inc. — Form D
Solarea Bio, Inc. of WALTHAM, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-09-11. The offering totals $14.8M, of which $11.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-09-11
- Form: D
- Accession: 0001823902-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $14.8M
- Amount sold: $11.3M
- Remaining: $3.5M
- Investors: 15
- Date of first sale: 2020-08-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-375330
Issuer
- Name: Solarea Bio, Inc.
- CIK: 0001823902
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 100 BEAVER STREET, WALTHAM, MA, 02453
- Phone: 585-704-8069
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Anula Jayasuriya | Director | San Francisco, CA |
| NEAL BHADKAMKAR | Director | Santa Monica, CA |
| MATTHEW WALKER | Director | Culver City, CA |
| GREGORY SIECZKIEWICZ | Director | WALTHAM, MA |
| CATHERINE BALSAM-SCHWABER | Director | WALTHAM, MA |
| CATHERINE BALSAM-SCHWABER | Executive Officer | WALTHAM, MA |
| ERIC SCHOTT | Executive Officer | WALTHAM, MA |
| ILISSA LARIMORE | Executive Officer | WALTHAM, MA |
| GERARDO TOLEDO | Director | WALTHAM, MA |
| GERARDO TOLEDO | Executive Officer | WALTHAM, MA |
Other filings by this issuer (3)
More